Cranberry proanthocyanidins have anti-biofilm properties against Pseudomonas aeruginosa

BMC Complementary and Alternative Medicine

Monique L van Hoek³  Weidong Zhou¹  Stephanie M Barksdale⁴  Robert K Ulrey² 

[1] Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA;Department of Biology, George Mason University, Manassas, Virginia, USA;National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, USA;School of Systems Biology, George Mason University, Manassas, Virginia, USA

关键词: Biofilm;    Pseudomonas aeruginosa;    Proanthocyanidins;    Cranberry;   

Others  :  1084682
DOI  :  10.1186/1472-6882-14-499

 received in 2014-04-27, accepted in 2014-12-11,  发布年份 2014

【 摘 要 】

Background

Bacteria within a biofilm are phenotypically more resistant to antibiotics, desiccation, and the host immune system, making it an important virulence factor for many microbes. Cranberry juice has long been used to prevent infections of the urinary tract, which are often related to biofilm formation. Recent studies have found that the A-type proanthocyanidins from cranberries have anti-biofilm properties against Escherichia coli.

Methods

Using crystal violet biofilm staining, resazurin metabolism assays, and confocal imaging, we examined the ability of A-type proanthocyanidins (PACs) to disrupt the biofilm formation of Pseudomonas aeruginosa. We used mass spectrometry to analyze the proteomic effects of PAC treatment. We also performed synergy assays and in vitro and in vivo infections to determine whether PACs, alone and in combination with gentamicin, could contribute to the killing of P. aeruginosa and the survival of cell lines and G. mellonella.

Results

Cranberry PACs reduced P. aeruginosa swarming motility. Cranberry PACs significantly disrupted the biofilm formation of P. aeruginosa. Proteomics analysis revealed significantly different proteins expressed following PAC treatment. In addition, we found that PACs potentiated the antibiotic activity of gentamicin in an in vivo model of infection using G. mellonella.

Conclusions

Results suggest that A-type proanthocyanidins may be a useful therapeutic against the biofilm-mediated infections caused by P. aeruginosa and should be further tested.

【 授权许可】

   
2014 Ulrey et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Flemming HC, Wingender J: The biofilm matrix. Nat Rev Microbiol 2010, 8(9):623-633.
• [2]Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284(5418):1318-1322.
• [3]Kuzminski LN: Cranberry juice and urinary tract infections: is there a beneficial relationship? Nutr Rev 1996, 54(11 Pt 2):S87-S90.
• [4]Fleet JC: New support for a folk remedy: cranberry juice reduces bacteriuria and pyuria in elderly women. Nutr Rev 1994, 52(5):168-170.
• [5]Borukh IF, Kirbaba VI, Senchuk GV: [Antimicrobial properties of cranberry]. Vopr Pitan 1972, 31(5):82.
• [6]Foo LY, Lu Y, Howell AB, Vorsa N: A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod 2000, 63(9):1225-1228.
• [7]Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M: A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005, 66(18):2281-2291.
• [8]Bodet C, Piche M, Chandad F, Grenier D: Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry. J Antimicrob Chemother 2006, 57(4):685-690.
• [9]Hidalgo G, Ponton A, Fatisson J, O’May C, Asadishad B, Schinner T, Tufenkji N: Induction of a state of iron limitation in uropathogenic Escherichia coli CFT073 by cranberry-derived proanthocyanidins as revealed by microarray analysis. Appl Environ Microbiol 2011, 77(4):1532-1535.
• [10]Ahuja S, Kaack B, Roberts J: Loss of fimbrial adhesion with the addition of Vaccinum macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol 1998, 159(2):559-562.
• [11]Sobota AE: Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984, 131(5):1013-1016.
• [12]Tapiainen T, Jauhiainen H, Jaakola L, Salo J, Sevander J, Ikaheimo I, Pirttila AM, Hohtola A, Uhari M: Biofilm formation and virulence of uropathogenic Escherichia coli in urine after consumption of cranberry-lingonberry juice. Eur J Clin Microbiol Infect Dis 2012, 31(5):655-662.
• [13]Yamanaka A, Kimizuka R, Kato T, Okuda K: Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 2004, 19(3):150-154.
• [14]Yamanaka A, Kouchi T, Kasai K, Kato T, Ishihara K, Okuda K: Inhibitory effect of cranberry polyphenol on biofilm formation and cysteine proteases of Porphyromonas gingivalis. J Periodontal Res 2007, 42(6):589-592.
• [15]Amer LS, Bishop BM, van Hoek ML: Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Biochem Biophys Res Commun 2010, 396(2):246-251.
• [16]O’May C, Ciobanu A, Lam H, Tufenkji N: Tannin derived materials can block swarming motility and enhance biofilm formation in Pseudomonas aeruginosa. Biofouling 2012, 28(10):1063-1076.
• [17]Bonifait L, Grenier D: Cranberry polyphenols: potential benefits for dental caries and periodontal disease. J Can Dent Assoc 2010, 76:a130.
• [18]Duarte S, Gregoire S, Singh AP, Vorsa N, Schaich K, Bowen WH, Koo H: Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett 2006, 257(1):50-56.
• [19]Matsushima M, Suzuki T, Masui A, Kasai K, Kouchi T, Takagi A, Shirai T, Mine T: Growth inhibitory action of cranberry on Helicobacter pylori. J Gastroenterol Hepatol 2008, 23(Suppl 2):S175-S180.
• [20]Yamanaka-Okada A, Sato E, Kouchi T, Kimizuka R, Kato T, Okuda K: Inhibitory effect of cranberry polyphenol on cariogenic bacteria. Bull Tokyo Dent Coll 2008, 49(3):107-112.
• [21]La VD, Labrecque J, Grenier D: Cytoprotective effect of proanthocyanidin-rich cranberry fraction against bacterial cell wall-mediated toxicity in macrophages and epithelial cells. Phytother Res 2009, 23(10):1449-1452.
• [22]Toivanen M, Ryynanen A, Huttunen S, Duricova J, Riihinen K, Torronen R, Lapinjoki S, Tikkanen-Kaukanen C: Binding of Neisseria meningitidis pili to berry polyphenolic fractions. J Agric Food Chem 2009, 57(8):3120-3127.
• [23]Pseudomonas aeruginosa: Infections and Treatment, Volume 12. New York: Informa Health Care; 1994.
• [24]Ciofu O, Hansen CR, Hoiby N: Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med 2013, 19(3):251-258.
• [25]Dean SN, Bishop BM, van Hoek ML: Susceptibility of pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37. Front Microbiol 2011, 2:128.
• [26]Tremblay J, Deziel E: Improving the reproducibility of Pseudomonas aeruginosa swarming motility assays. J Basic Microbiol 2008, 48(6):509-515.
• [27]Durham-Colleran MW, Verhoeven AB, van Hoek ML: Francisella novicida forms in vitro biofilms mediated by an orphan response regulator. Microb Ecol 2010, 59(3):457-465.
• [28]Dean SN, Bishop BM, van Hoek ML: Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 2011, 11:114. BioMed Central Full Text
• [29]O’Toole GA: Microtiter dish biofilm formation assay. J Visual Exp 2011, 47:2437.
• [30]Ahmad S, Hunter L, Qin A, Mann BJ, van Hoek ML: Azithromycin effectiveness against intracellular infections of Francisella. BMC Microbiol 2010, 10:123. BioMed Central Full Text
• [31]Hall MJ, Middleton RF, Westmacott D: The fractional inhibitory concentration (FIC) index as a measure of synergy. J Antimicrob Chemother 1983, 11(5):427-433.
• [32]Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, Blais J, Cho D, Chamberland S, Renau T, Leger R, Hecker S, Watkins W, Hoshino K, Ishida H, Lee VJ: Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001, 45(1):105-116.
• [33]Tolker-Nielsen T, Sternberg C: Growing and Analyzing Biofilms in Flow Chambers. In Current Protocols in Microbiology. Hoboken, NJ: John Wiley & Sons, Inc; 2005.
• [34]Zhou W, Capello M, Fredolini C, Racanicchi L, Piemonti L, Liotta LA, Novelli F, Petricoin EF: Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. J Proteome Res 2012, 11(2):554-563.
• [35]Elias JE, Gygi SP: Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 2007, 4(3):207-214.
• [36]McKenney ES, Sargent M, Khan H, Uh E, Jackson ER, San Jose G, Couch RD, Dowd CS, van Hoek ML: Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy. PLoS One 2012, 7(10):e38167.
• [37]O’Loughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL: A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc Natl Acad Sci U S A 2013, 110(44):17981-17986.
• [38]Wu H, Song Z, Hentzer M, Andersen JB, Molin S, Givskov M, Hoiby N: Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J Antimicrob Chemother 2004, 53(6):1054-1061.
• [39]Lin B, Johnson BJ, Rubin RA, Malanoski AP, Ligler FS: Iron chelation by cranberry juice and its impact on Escherichia coli growth. BioFactors (Oxford, England) 2011, 37(2):121-130.
• [40]Andres MT, Viejo-Diaz M, Perez F, Fierro JF: Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2005, 49(4):1613-1616.
• [41]Woolfrey BF, Lally RT, Ederer MN, Quall CO: Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin. J Clin Microbiol 1984, 19(4):502-505.
• [42]Koo H, Duarte S, Murata RM, Scott-Anne K, Gregoire S, Watson GE, Singh AP, Vorsa N: Influence of cranberry proanthocyanidins on formation of biofilms by Streptococcus mutans on saliva-coated apatitic surface and on dental caries development in vivo. Caries Res 2010, 44(2):116-126.
• [43]Leshem R, Maharshak I, Ben Jacob E, Ofek I, Kremer I: The effect of nondialyzable material (NDM) cranberry extract on formation of contact lens biofilm by Staphylococcus epidermidis. Invest Ophthalmol Vis Sci 2011, 52(7):4929-4934.
• [44]Feldman M, Weiss EI, Ofek I, Steinberg D: Interference of cranberry constituents in cell-cell signaling system of Vibrio harveyi. Curr Microbiol 2009, 59(4):469-474.
• [45]Labrecque J, Bodet C, Chandad F, Grenier D: Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother 2006, 58(2):439-443.
• [46]Polak D, Naddaf R, Shapira L, Weiss EI, Houri-Haddad Y: Protective potential of non-dialyzable material fraction of cranberry juice on the virulence of P. gingivalis and F. nucleatum mixed infection. J Periodontol 2013, 84(7):1019-1025.
• [47]O’May C, Tufenkji N: The swarming motility of Pseudomonas aeruginosa is blocked by cranberry proanthocyanidins and other tannin-containing materials. Appl Environ Microbiol 2011, 77(9):3061-3067.
• [48]Foo LY, Lu Y, Howell AB, Vorsa N: The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000, 54(2):173-181.
• [49]Cai Y, Wang R, An MM, Liang BB: Iron-Depletion prevents biofilm formation in Pseudomonas Aeruginosa through twitching mobility and quorum sensing. Brazilian J Microbiol 2010, 41(1):37-41.
• [50]Farha MA, Brown ED: Discovery of antibiotic adjuvants. Nat Biotechnol 2013, 31(2):120-122.